Department of Anatomy and Neurobiology, Northeast Ohio Medical University, Rootstown, OH, 44272, USA.
Department of Anatomy and Neurobiology, Northeast Ohio Medical University, Rootstown, OH, 44272, USA.
Osteoarthritis Cartilage. 2020 Aug;28(8):1102-1110. doi: 10.1016/j.joca.2020.04.014. Epub 2020 May 12.
Recent studies have shown that tRNA-derived RNA fragments (tRFs) are novel regulators of post-transcriptional gene expression. However, the expression profiles and their role in post-transcriptional gene regulation in chondrocytes is unknown. Here, we determined tRFs expression profile and explored tRF-3003a role in post-transcriptional gene regulation in IL-1β stimulated chondrocytes.
We used qPCR arrays to determine tRNAs and tRFs expression in age- and sex-matched primary human OA chondrocytes and TC28/I2 cells stimulated with IL-1β. Chondrocytes were transfected with tRNA-Cys overexpression plasmid or tRF-3003a mimic and 3'UTR luciferase reporter plasmids of mRNAs harboring predicted tRF target "seed sequence". The AGO-RNA-induced silencing complex (AGO-RISC)-dependent repressive activity of tRF-3003a was determined by siRNA-mediated knockdown of AGO2.
IL-1β increased the expression levels of specific tRNAs and of tRF-3003a, a type 3 tRF produced by the cleavage of tRNA-Cys. tRF-3003a "seed sequence" was identified in the 3'UTR of JAK3 mRNA and tRNA-Cys overexpression or transfection of a tRF-3003a mimic in chondrocytes downregulated JAK3 expression and significantly reduced the activity of the 3'UTR reporter. RIP assay showed enrichment of tRF-3003a into AGO2/RISC in IL-1β treated chondrocytes. The suppressive effect of tRF-3003a on JAK3 3'UTR reporter was abrogated with siRNA-mediated depletion of AGO2.
We demonstrate that under pathological conditions chondrocytes display perturbations in the expression profile of specific tRNAs and tRFs. Furthermore, a specific tRF namely tRF-3003a can post-transcriptionally regulate JAK3 expression via AGO/RISC formation in chondrocytes. Identification of this novel mechanism may be of value in the design of precision therapies for OA.
最近的研究表明,tRNA 衍生的 RNA 片段(tRFs)是转录后基因表达的新型调节因子。然而,tRFs 在软骨细胞中的表达谱及其在后转录基因调控中的作用尚不清楚。在这里,我们确定了 tRFs 的表达谱,并探讨了 tRF-3003a 在 IL-1β 刺激的软骨细胞中转录后基因调控中的作用。
我们使用 qPCR 阵列来确定年龄和性别匹配的原发性人 OA 软骨细胞和 TC28/I2 细胞中 tRNA 和 tRFs 的表达,这些细胞用 IL-1β 刺激。将 tRNA-Cys 过表达质粒或 tRF-3003a 模拟物转染到含有预测的 tRF 靶“种子序列”的 mRNA 的 3'UTR 荧光素酶报告质粒中。通过 siRNA 介导的 AGO2 敲低来确定 tRF-3003a 的 AGO-RNA 诱导沉默复合物(AGO-RISC)依赖性抑制活性。
IL-1β 增加了特定 tRNA 和 tRF-3003a 的表达水平,tRF-3003a 是由 tRNA-Cys 切割产生的 3 型 tRF。tRF-3003a 的“种子序列”位于 JAK3 mRNA 的 3'UTR 中,软骨细胞中转染 tRNA-Cys 过表达或 tRF-3003a 模拟物可下调 JAK3 表达,并显著降低 3'UTR 报告基因的活性。RIP 测定显示,IL-1β 处理的软骨细胞中 tRF-3003a 富集到 AGO2/RISC 中。siRNA 介导的 AGO2 耗竭可消除 tRF-3003a 对 JAK3 3'UTR 报告基因的抑制作用。
我们证明,在病理条件下,软骨细胞显示特定 tRNA 和 tRFs 的表达谱发生了改变。此外,一种特定的 tRF,即 tRF-3003a,可通过 AGO/RISC 在软骨细胞中形成,从而转录后调节 JAK3 的表达。鉴定这种新的机制可能对设计 OA 的精准治疗具有价值。